Stockreport

XBiotech Inc.: Attractive Takeover Target After Compelling Phase II Atopic Dermatitis Results [Seeking Alpha]

XBiotech Inc.  (XBIT) 
Last xbiotech inc. earnings: 8/9 03:01 pm Check Earnings Report
US:NASDAQ Investor Relations: xbiotech.com/about/investors.html
PDF XBiotech Inc.: Attractive Takeover Target After Compelling Phase II Atopic Dermatitis ResultsSummaryEarly results in Phase II Atopic Dermatitis (AD) trial delivers stell [Read more]